PubChem Compound Summary for CID 9941379, Bremelanotide
Women who were taking both HRT and tirzepatide had: A greater median percentage weight loss (17% vs 14%) A higher rate of achieving 20%+ weight loss (45% vs 18%) These findings suggest that concomitant HRT may positively influence weight loss response when using incretin-based therapies like tirzepatide
In SURMOUNT-1 , a 72-week Phase 3 double-blind trial in 2,539 adults with obesity (or overweight with a complication) but without diabetes, once-weekly tirzepatide produced mean weight changes of 15.0% (5 mg), 19.5% (10 mg), and 20.9% (15 mg) versus 3.1% with placebo, with 5057% of participants on the higher doses losing at least 20% of body weight
My program addresses both components through nutritional education, the use of FDA approved medications, and supportive counseling to help you safely and efficiently achieve your goals
The mechanism is most parsimoniously explained as telogen effluvium secondary to rapid weight loss and metabolic stress
Obesity: The impact on health, quality of life and economic wellbeing Obesity is arguably the defining health issue of the 21st Century
